Tinda, Sayde A.

HRN: 23-64-95  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/03/2023
09/10/2023
IV
75mg
Q6
Anemia Etiology To Be Determined, Mumps
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: